GeneDx Holdings Corp. (WGSWW)
NASDAQ: WGSWW · Real-Time Price · USD
0.250
+0.020 (8.70%)
Feb 20, 2025, 4:00 PM EST - Market closed
GeneDx Holdings Market Cap
GeneDx Holdings has a market cap or net worth of $3.06 billion as of February 20, 2025. Its market cap has increased by 2,976.43% in one year.
Market Cap
3.06B
Enterprise Value
3.03B
1-Year Change
2,976.43%
Ranking
Category
Stock Price
$0.25
Market Cap Chart
Since November 4, 2020, GeneDx Holdings's market cap has decreased from $17.90B to $3.06B, a decrease of -82.92%. That is a compound annual growth rate of -33.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2025 | 3.06B | 44.82% |
| Dec 31, 2024 | 2.11B | 2,866.28% |
| Dec 29, 2023 | 71.18M | -30.24% |
| Dec 30, 2022 | 102.04M | -90.52% |
| Dec 31, 2021 | 1.08B | -94.66% |
| Dec 31, 2020 | 20.16B | 12.65% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 779.93B |
| UnitedHealth Group | 468.31B |
| Johnson & Johnson | 380.62B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.04B |
| AstraZeneca | 230.61B |
| Abbott Laboratories | 229.05B |
| Intuitive Surgical | 216.74B |